Method for Diagnosing Scleroderma
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jul 2, 2015
app pub date -
Jul 23, 2013
filing date -
Jul 23, 2012
priority date (Note) -
Abandoned
status (Latency Note)
![]() |
A preliminary load of PAIR data current through [] has been loaded. Any more recent PAIR data will be loaded within twenty-four hours. |
PAIR data current through []
A preliminary load of cached data will be loaded soon.
Any more recent PAIR data will be loaded within twenty-four hours.
![]() |
Next PAIR Update Scheduled on [ ] |

Importance

US Family Size
|
Non-US Coverage
|
Abstract
The present invention relates to an in vitro method for diagnosing scleroderma in a subject, said method comprising the step of detecting in a biological sample obtained from the subject one or more autoantibodies recognizing one or more protein biomarkers selected from the group of proteins consisting of THEX1, AIF1, FGF2, EphB2, CLK1 and ANKS6.
First Claim
all claims..Other Claims data not available
Family

- 15 United States
- 10 France
- 8 Japan
- 7 China
- 5 Korea
- 2 Other
Patent Owner(s)
Patent Owner | Address | |
---|---|---|
INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) | 101 RUE DE TOLBIAC PARIS 75013 | |
UNIVERSITE D'AIX-MARSEILLE | 58 BD CHARLES LIVON MARSEILLE 13007 | |
ASSISTANCE PUBLIQUE-HOPITAUX DE MARSEILLE | 80 RUE BROCHIER MARSEILLE F-13005 |
International Classification(s)

- 2013 Application Filing Year
- G01N Class
- 9056 Applications Filed
- 7640 Patents Issued To-Date
- 84.37 % Issued To-Date
Inventor(s)
Inventor Name | Address | # of filed Patents | Total Citations |
---|---|---|---|
Auger, Isabelle | Marseille Cedex 09, FR | 7 | 11 |
# of filed Patents : 7 Total Citations : 11 | |||
Lambert, Nathalie | Marseille Cedex 09, FR | 3 | 2 |
# of filed Patents : 3 Total Citations : 2 | |||
Roudier, Jean | Marseille Cedex 09, FR | 8 | 11 |
# of filed Patents : 8 Total Citations : 11 |
Cited Art Landscape
- No Cited Art to Display

Patent Citation Ranking
- 1 Citation Count
- G01N Class
- 23.45 % this patent is cited more than
- 10 Age
Forward Cite Landscape
- No Forward Cites to Display

Maintenance Fees
Fee | Large entity fee | small entity fee | micro entity fee | due date |
---|---|---|---|---|
11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Jan 2, 2027 |
Fee | Large entity fee | small entity fee | micro entity fee |
---|---|---|---|
Surcharge - 11.5 year - Late payment within 6 months | $160.00 | $80.00 | $40.00 |
Surcharge after expiration - Late payment is unavoidable | $700.00 | $350.00 | $175.00 |
Surcharge after expiration - Late payment is unintentional | $1,640.00 | $820.00 | $410.00 |
Full Text

Legal Events
- No Legal Status data available.

Matter Detail

Renewals Detail
